Janneke C. Verhoeven-Van Lith
Tilburg, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Scrutinizing pathogenicity of the USH2A c.2276 G > T; p.(Cys759Phe) variant.
Journal: NPJ genomic medicine
Published: January 25, 2022
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial.
Journal: Ophthalmology. Retina
Published: January 05, 2020
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial.
Journal: Ophthalmology. Retina
Published: August 20, 2019
Achieving balance in the treatment and monitoring of neovascular age-related macular degeneration in the real world: lessons from the Netherlands cohort of the AURA study.
Journal: Acta ophthalmologica
Published: October 16, 2018
A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.
Journal: Acta ophthalmologica
Published: March 05, 2014
Mutations in MFSD8, encoding a lysosomal membrane protein, are associated with nonsyndromic autosomal recessive macular dystrophy.
Journal: Ophthalmology
Published: February 17, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026